Core Scientific, Inc./tx (CORZ): who owns it and who trades it
As of Nov 16, 2026, CORZ insiders reported 53 open-market sales worth $6.6M and 4 purchases worth $444K in the last 12 months, with 13% of the sale value made under pre-set 10b5-1 plans. The largest seller was Todd M Duchene (See remarks), with $6.6M. 8 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Core Scientific
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns CORZ
412 funds and institutions reported CORZ shares worth $9.7B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 8.8%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 28.12M | 8.85% | $720M | +14% |
| Situational Awareness LP | 26.01M | 8.18% | $666M | No change |
| Jericho Capital Asset Management L.P. | 22.88M | 7.20% | $586M | +95% |
| Vanguard Portfolio Management LLC | 18.66M | 5.87% | $478M | +0% |
| UBS Group AG | 15.89M | 5.00% | $407M | -38% |
| Vanguard Capital Management LLC | 13.80M | 4.34% | $353M | +3% |
| Two Sigma Investments, LP | 10.28M | 3.23% | $263M | +84% |
| Value Aligned Research Advisors, LLC | 9.19M | 2.89% | $235M | +19% |
| Two Seas Capital LP | 9.03M | 2.84% | $231M | -44% |
| Geode Capital Management, LLC | 8.50M | 2.67% | $245M | +9% |
| State Street Corp | 7.75M | 2.44% | $198M | +6% |
| California State Teachers Retirement System | 7.48M | 2.35% | $292M | – |
| Valiant Capital Management, L.P. | 7.47M | 2.35% | $191M | +9% |
| Ascentis Wealth Management, LLC | 7.28M | 2.29% | $186M | No change |
| Jane Street Group, LLC | 6.47M | 2.04% | $166M | – |
| Morgan Stanley | 6.34M | 1.99% | $162M | +83% |
| T. Rowe Price Associates | 6.22M | 1.96% | $159M | +779% |
| Alliancebernstein L.P. | 5.62M | 1.77% | $84.1M | – |
| JPMorgan Chase & Co | 5.45M | 1.72% | $142M | – |
| Oaktree Capital Management LP | 4.99M | 1.57% | $128M | -47% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, CORZ insiders reported $444K of open-market purchases and $6.6M of sales. 13% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Todd M Duchene | See remarks | Sale plan | 7,900 | $12.39 | $97.9K | Form 4 |
| Nov 9, 2026 | Todd M Duchene | See remarks | Sale plan | 2,100 | $12.70 | $26.7K | Form 4 |
| Nov 2, 2026 | Todd M Duchene | See remarks | Sale plan | 9,900 | $12.78 | $126K | Form 4 |
| Nov 2, 2026 | Todd M Duchene | See remarks | Sale plan | 100 | $13.37 | $1.3K | Form 4 |
| Oct 26, 2026 | Todd M Duchene | See remarks | Sale plan | 4,500 | $13.27 | $59.7K | Form 4 |
| Oct 26, 2026 | Todd M Duchene | See remarks | Sale plan | 5,500 | $13.80 | $75.9K | Form 4 |
| Oct 19, 2026 | Todd M Duchene | See remarks | Sale plan | 10,000 | $13.87 | $139K | Form 4 |
| Oct 12, 2026 | Todd M Duchene | See remarks | Sale plan | 10,000 | $15.12 | $151K | Form 4 |
| Oct 5, 2026 | Todd M Duchene | See remarks | Sale plan | 10,000 | $16.31 | $163K | Form 4 |
| Sep 28, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $16.76 | $168K | Form 4 |
| Sep 21, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $18.37 | $184K | Form 4 |
| Sep 15, 2026 | Eric Stanton Weiss | Director | Purchase | 6,000 | $16.33 | $98K | Form 4 |
| Sep 14, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $17.14 | $171K | Form 4 |
| Sep 8, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $18.67 | $187K | Form 4 |
| Aug 31, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $16.23 | $162K | Form 4 |
| Aug 24, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $17.45 | $174K | Form 4 |
| Aug 20, 2026 | Elizabeth Crain | Director | Purchase | 6,000 | $18.33 | $110K | Form 4 |
| Aug 18, 2026 | Eric Stanton Weiss | Director | Purchase | 7,000 | $19.19 | $134K | Form 4 |
| Aug 17, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $20.10 | $201K | Form 4 |
| Aug 10, 2026 | Todd M Duchene | See remarks | Sale | 9,000 | $19.90 | $179K | Form 4 |
| Aug 10, 2026 | Todd M Duchene | See remarks | Sale | 1,000 | $20.65 | $20.6K | Form 4 |
| Aug 3, 2026 | Todd M Duchene | See remarks | Sale | 7,500 | $22.62 | $170K | Form 4 |
| Aug 3, 2026 | Todd M Duchene | See remarks | Sale | 1,500 | $21.55 | $32.3K | Form 4 |
| Aug 3, 2026 | Todd M Duchene | See remarks | Sale | 1,000 | $20.39 | $20.4K | Form 4 |
| Jul 27, 2026 | Todd M Duchene | See remarks | Sale | 100 | $22.49 | $2.2K | Form 4 |
| Jul 27, 2026 | Todd M Duchene | See remarks | Sale | 1,600 | $21.89 | $35K | Form 4 |
| Jul 27, 2026 | Todd M Duchene | See remarks | Sale | 8,300 | $20.75 | $172K | Form 4 |
| Jul 20, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $22.30 | $223K | Form 4 |
| Jul 13, 2026 | Todd M Duchene | See remarks | Sale | 300 | $23.01 | $6.9K | Form 4 |
| Jul 13, 2026 | Todd M Duchene | See remarks | Sale | 9,700 | $22.43 | $218K | Form 4 |
| Jul 6, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $22.63 | $226K | Form 4 |
| Jun 29, 2026 | Todd M Duchene | See remarks | Sale | 8,800 | $25.99 | $229K | Form 4 |
| Jun 29, 2026 | Todd M Duchene | See remarks | Sale | 100 | $27.95 | $2.8K | Form 4 |
| Jun 29, 2026 | Todd M Duchene | See remarks | Sale | 1,100 | $27.42 | $30.2K | Form 4 |
| Jun 22, 2026 | Todd M Duchene | See remarks | Sale | 7,600 | $29.11 | $221K | Form 4 |
| Jun 22, 2026 | Todd M Duchene | See remarks | Sale | 2,400 | $29.88 | $71.7K | Form 4 |
| Jun 15, 2026 | Todd M Duchene | See remarks | Sale | 100 | $28.79 | $2.9K | Form 4 |
| Jun 15, 2026 | Todd M Duchene | See remarks | Sale | 9,900 | $28.19 | $279K | Form 4 |
| Jun 8, 2026 | Todd M Duchene | See remarks | Sale | 5,500 | $26.64 | $147K | Form 4 |
| Jun 8, 2026 | Todd M Duchene | See remarks | Sale | 4,500 | $27.11 | $122K | Form 4 |
| Jun 1, 2026 | Todd M Duchene | See remarks | Sale | 5,500 | $28.76 | $158K | Form 4 |
| Jun 1, 2026 | Todd M Duchene | See remarks | Sale | 3,200 | $28.27 | $90.5K | Form 4 |
| Jun 1, 2026 | Todd M Duchene | See remarks | Sale | 1,300 | $26.93 | $35K | Form 4 |
| May 26, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $26.25 | $262K | Form 4 |
| May 18, 2026 | Todd M Duchene | See remarks | Sale | 9,600 | $23.12 | $222K | Form 4 |
| May 18, 2026 | Todd M Duchene | See remarks | Sale | 400 | $23.76 | $9.5K | Form 4 |
| May 11, 2026 | Todd M Duchene | See remarks | Sale | 2,600 | $22.82 | $59.3K | Form 4 |
| May 11, 2026 | Todd M Duchene | See remarks | Sale | 7,400 | $23.39 | $173K | Form 4 |
| May 4, 2026 | Todd M Duchene | See remarks | Sale | 9,900 | $20.85 | $206K | Form 4 |
| May 4, 2026 | Todd M Duchene | See remarks | Sale | 100 | $21.53 | $2.2K | Form 4 |
| Apr 27, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $20.94 | $209K | Form 4 |
| Apr 20, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $19.80 | $198K | Form 4 |
| Apr 13, 2026 | Todd M Duchene | See remarks | Sale | 400 | $18.99 | $7.6K | Form 4 |
| Apr 13, 2026 | Todd M Duchene | See remarks | Sale | 9,600 | $18.61 | $179K | Form 4 |
| Apr 6, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $16.49 | $165K | Form 4 |
| Apr 1, 2026 | Todd M Duchene | See remarks | Sale | 10,000 | $15.25 | $152K | Form 4 |
| Mar 9, 2026 | Eric Stanton Weiss | Director | Purchase | 7,000 | $14.53 | $102K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Todd M Duchene | See remarks | – | $6.6M | Nov 9, 2026 |
| Eric Stanton Weiss | Director | $334K | – | Sep 15, 2026 |
| Elizabeth Crain | Director | $110K | – | Aug 20, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
CORZ short interest
Very high short interest. 22.7% of CORZ shares are sold short: about 1 share in 4. Over the last 12 reports the number of shares short went up 14%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 73.01M CORZ shares were sold short, 22.7% of the shares outstanding, down 4.7% from the report before. At the average daily volume of 14.47M shares, buying them all back would take about 5.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 73.01M | 22.72% | -5% | 14.47M | 5.0 |
| Oct 15, 2026 | 76.63M | 23.85% | +16% | 14.85M | 5.2 |
| Sep 30, 2026 | 65.99M | 20.54% | +5% | 11.39M | 5.8 |
| Sep 15, 2026 | 63.13M | 19.65% | -3% | 10.78M | 5.9 |
| Aug 31, 2026 | 64.79M | 20.16% | +2% | 11.02M | 5.9 |
| Aug 14, 2026 | 63.44M | 19.74% | +0% | 12.34M | 5.1 |
| Jul 31, 2026 | 63.14M | 19.65% | -0% | 13.82M | 4.6 |
| Jul 15, 2026 | 63.36M | 19.93% | -8% | 11.03M | 5.7 |
| Jun 30, 2026 | 69.09M | 21.74% | -8% | 12.39M | 5.6 |
| Jun 15, 2026 | 74.72M | 23.51% | +4% | 12.05M | 6.2 |
| May 29, 2026 | 71.85M | 22.60% | +12% | 13.25M | 5.4 |
| May 15, 2026 | 64.07M | 20.16% | -2% | 18.00M | 3.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Core Scientific company events
Core Scientific filed 20 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership, restatement). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Sep 10, 2026AnnouncementShared information with investors. Filing
- Aug 27, 2026AgreementCore Scientific, Inc. entered into a Credit Agreement, among the Company, as borrower, each issuing bank and lender party thereto from time to time, JPMorgan Chase Bank, N.A. as administrative agent and collateral agent. Filing
- Aug 14, 2026AnnouncementCore Scientific, Inc., a Delaware corporation, completed the previously announced acquisition of Polaris DS LLC, a Nevada limited liability company, contemplated by the Agreement and Plan of Merger, dated as of May 5, 2026, by and among the Company, Polar Merger Sub, LLC, a Nevada limited liability… Filing
- Jul 29, 2026LeadershipThe Company announced the appointment of Mark W. Adams, as a member of the Board of Directors, effective immediately. Filing
- Jul 28, 2026ResultsReleased financial results. Filing
- Jul 28, 2026SharesSold new shares outside a public offering. Filing
- May 26, 2026LeadershipThe Company announced the appointment of Steve M. Smith, as a member of the Board and the Nominating and Corporate Governance Committee of the Board, effective immediately. Filing
- May 15, 2026VoteReported shareholder vote results. Filing
- May 6, 2026ResultsReleased financial results. Filing
- May 6, 2026AgreementCore Scientific Finance I LLC, a wholly-owned indirect subsidiary of Core Scientific, Inc., completed its previously announced private offering of $3.3 billion of its 7.750% Senior Secured Notes due 2031. Filing
- May 6, 2026AgreementCore Scientific, Inc., a Delaware corporation, entered into an agreement and plan of merger with Polar Merger Sub, LLC, a Nevada limited liability company and wholly owned subsidiary of the Company, Polaris DS LLC, a Nevada limited liability company, Top Access Enterprises Limited, a company… Filing
- May 5, 2026LeadershipThe Board of Directors of Core Scientific, Inc. appointed Jorge Ray as the Company’s Principal Accounting Officer, effective May 7, 2026. Filing
- Apr 27, 2026AnnouncementShared information with investors. Filing
- Apr 21, 2026AnnouncementShared information with investors. Filing
- Mar 23, 2026AgreementCore Scientific, Inc. entered into Amendment No. 1 to Delayed-Draw Bridge Credit Agreement, by and among the Company, as borrower, Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent (in such capacity, the “Agent”), and JPMorgan Chase Bank, N.A., as amendment no. 1… Filing
- Mar 6, 2026AgreementCore Scientific, Inc. entered into a loan facility Credit Agreement, by and among the Company, as borrower, the lenders party thereto from time to time and Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent. Filing
- Mar 2, 2026RestatementThe Audit Committee of the Board of Directors of the Company, in consultation with management, determined that the Company’s consolidated financial statements for the three and six months ended June 30, 2024, the three and nine months ended September 30, 2024, the year ended December 31, 2024, the… Filing
- Feb 19, 2026LeadershipAmended an earlier report. Separately, at regularly scheduled meeting of the Company’s Board of Directors held on February 18, 2026, Jordan Levy, the Chairman of the Board of Directors, notified the Company and the Board of Directors that he will not stand for re-election at the 2026 Annual Meeting. Filing
- Feb 18, 2026LeadershipJordan Levy, the Chairman of the Board of Directors, notified the Company and the Board of Directors that he will not stand for re-election at the 2026 Annual Meeting. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Core Scientific financials
Famous investors that hold CORZ
8 of the 50 well-known investors we track reported holding CORZ in their latest 13F filing. The largest position is Howard Marks's, worth $128M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Howard Marks · Oaktree Capital Management | Q2 2026 | 4.99M | $128M | 3.4% | -47% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 9.17M | $85.2M | 0.1% | -1% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 4.19M | $67M | 0.0% | +4% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 3.56M | $56.9M | 0.1% | +7% |
| Israel Englander · Millennium Management | Q3 2026 | 2.74M | $43.8M | 0.0% | -22% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 1.82M | $29.1M | 0.1% | -16% |
| Larry Robbins · Glenview Capital Management | Q3 2026 | 1.59M | $25.4M | 0.5% | New |
| George Soros · Soros Fund Management | Q3 2026 | 2.25M | $21M | 0.4% | No change |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named CORZ in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Citadel Securities GP LLC | 13G/A | 3.5% |
| Nov 16, 2026 | Citadel Securities GP LLC | 13G/A | 3.5% |
| Nov 6, 2026 | JANE STREET GROUP, LLC | 13G/A | 2.9% |
| Nov 6, 2026 | JANE STREET GROUP, LLC | 13G/A | 2.9% |
| Oct 28, 2026 | MFN Partners, LP | 13G | 7.6% |
| Oct 28, 2026 | MFN Partners, LP | 13G | 7.6% |
Questions about Core Scientific, Inc./tx (CORZ) stock
Who owns the most CORZ stock?
The largest reported owner of Core Scientific, Inc./tx (CORZ) is BlackRock, Inc., with 8.8% of the company. In total, 412 funds and institutions reported holding CORZ at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are CORZ insiders buying or selling?
In the last 12 months, CORZ insiders reported 4 open-market purchases worth $444K and 53 sales worth $6.6M. The latest trade was on Nov 9, 2026. See every trade.
What is the short interest in CORZ?
As of Oct 30, 2026, 73.01M CORZ shares were sold short, 22.7% of the shares outstanding, down 4.7% from the report before. At the average daily volume of 14.47M shares, buying them all back would take about 5.0 trading days (days to cover). See the history.
Which famous investors hold CORZ?
8 of the 50 well-known investors we track reported CORZ in their latest 13F filing, including Howard Marks, Steve Cohen, Ken Griffin. The largest position is worth $128M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.